May 16, 2025

FDA Clears First Blood Test for Alzheimer’s

The FDA has cleared the first blood-based test to aid in diagnosing Alzheimer’s disease, offering a less invasive alternative to positron emission tomography scans and cerebrospinal fluid testing for cognitively impaired patients.

Conexiant

May 16, 2025

Delandistrogene Moxeparvovec: Efficacy Evidence Questioned

The AAN Guidelines Subcommittee review finds delandistrogene moxeparvovec for DMD failed to meet primary functional outcomes despite FDA approval.

Conexiant

May 15, 2025

Assistant Professor Salary Gaps Persist Nationwide

Persistent salary disparities by gender, race, and ethnicity were identified among more than 45,000 U.S. assistant professors, with underrepresented in medicine women learning the least across all specialties.

Conexiant

May 15, 2025

Men With Broken Heart Syndrome Have Twice the Mortality Risk: Study

A large U.S. study of nearly 200,000 Takotsubo cardiomyopathy cases found persistently high mortality—especially among men—despite rising incidence and increased recognition from 2016 to 2020.

Conexiant

May 15, 2025

Visual Difficulty, Falls, and Mortality

Recurrent falls were associated with a nearly 50% increased hazard of mortality.

Conexiant

May 12, 2025

Delayed Puberty: Diabetes Risk Signal?

"Our results are surprising as delayed puberty is generally considered a benign condition."

Conexiant

May 12, 2025

Yearly Blood Tests May Cut Cancer Deaths by 21%

A state-transition model demonstrates that multicancer early detection blood tests significantly reduce late-stage cancer diagnoses and mortality, with annual screening intervals showing superior outcomes compared to biennial testing.

Conexiant

May 09, 2025

Self-Harm Risk Rises Prior to and Following Gabapentinoids 

Researchers tracked over 10,000 patients and found the risk of self-harm was highest before starting gabapentinoids and again shortly after stopping, highlighting key periods for clinical monitoring.

Conexiant

May 09, 2025

Few Patients With STI Receive Recommended Antibiotics: Study

A 5-year national study of over 8,800 cases found that fewer than 40% of patients with gonorrhea and just 14% of those with chlamydia were treated with CDC-recommended antibiotics in U.S. primary care.

Conexiant